Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
73.64 USD | -8.18% | -4.33% | +295.70% |
May. 06 | Viking Therapeutics Insider Sold Shares Worth $4,986,008, According to a Recent SEC Filing | MT |
May. 03 | Wall St set to open sharply higher on soft jobs data | RE |
Financials (USD)
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 8.12B |
---|---|---|---|---|---|
Net income 2024 * | -119M | Net income 2025 * | -172M | EV / Sales 2024 * | - |
Net cash position 2024 * | 895M | Net cash position 2025 * | 749M | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-65.9
x | P/E ratio 2025 * |
-47.5
x | Employees | 28 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 94% |
Latest transcript on Viking Therapeutics, Inc.
1 day | -8.18% | ||
1 week | -4.33% | ||
Current month | -7.46% | ||
1 month | +3.91% | ||
3 months | +140.81% | ||
6 months | +652.97% | ||
Current year | +295.70% |
Managers | Title | Age | Since |
---|---|---|---|
Brian Lian
FOU | Founder | 58 | 12-09-23 |
Gregory Zante
DFI | Director of Finance/CFO | 53 | 16-01-04 |
Marianne Mancini
COO | Chief Operating Officer | 59 | 15-04-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Matthew Foehr
BRD | Director/Board Member | 51 | 14-04-30 |
J. Singleton
BRD | Director/Board Member | 71 | 14-04-30 |
Charles Rowland
BRD | Director/Board Member | 65 | 17-06-30 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.13% | 2 M€ | -.--% | ||
0.06% | 7 M€ | -.--% | - | |
0.00% | 0 M€ | +3.63% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-10 | 73.64 | -8.18% | 3,993,178 |
24-05-09 | 80.2 | +0.36% | 2,416,825 |
24-05-08 | 79.91 | +0.38% | 1,799,726 |
24-05-07 | 79.61 | +1.79% | 3,683,622 |
24-05-06 | 78.21 | +1.61% | 3,197,262 |
Delayed Quote Nasdaq, May 10, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+295.70% | 8.12B | |
+3.91% | 109B | |
+10.87% | 105B | |
+1.28% | 22.25B | |
-13.14% | 22.09B | |
-7.05% | 18.68B | |
-38.36% | 17.58B | |
-10.66% | 16.85B | |
+3.75% | 13.76B | |
+36.70% | 12.46B |
- Stock Market
- Equities
- VKTX Stock